| __timestamp | Opthea Limited | Xencor, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 3401685 | 18516000 |
| Thursday, January 1, 2015 | 4284228 | 34140000 |
| Friday, January 1, 2016 | 3581295 | 51872000 |
| Sunday, January 1, 2017 | 4838300 | 71772000 |
| Monday, January 1, 2018 | 24891534 | 97501000 |
| Tuesday, January 1, 2019 | 31347891 | 118590000 |
| Wednesday, January 1, 2020 | 17480747 | 169802000 |
| Friday, January 1, 2021 | 34710152 | 192507000 |
| Saturday, January 1, 2022 | 108459978 | 199563000 |
| Sunday, January 1, 2023 | 181563523 | 253598000 |
| Monday, January 1, 2024 | 176326321 |
Unveiling the hidden dimensions of data
In the competitive world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Opthea Limited and Xencor, Inc. have been at the forefront of this race since 2014. Over the past decade, Xencor has consistently outpaced Opthea, with its R&D expenses growing by over 1,270% from 2014 to 2023. Opthea, while trailing, has shown a remarkable increase of over 5,200% in the same period. Notably, in 2023, Xencor's R&D spending reached its peak, surpassing Opthea by approximately 40%. However, data for 2024 is incomplete, leaving room for speculation on future trends. This comparison highlights the dynamic nature of innovation investment in the biotech sector, where strategic spending can lead to groundbreaking advancements.
Comparing Innovation Spending: Eli Lilly and Company and Opthea Limited
Research and Development: Comparing Key Metrics for United Therapeutics Corporation and Opthea Limited
Who Prioritizes Innovation? R&D Spending Compared for Neurocrine Biosciences, Inc. and Xencor, Inc.
Blueprint Medicines Corporation vs Opthea Limited: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Opthea Limited and CymaBay Therapeutics, Inc.
Analyzing R&D Budgets: Opthea Limited vs Veracyte, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Alpine Immune Sciences, Inc. and Xencor, Inc.
R&D Spending Showdown: Ultragenyx Pharmaceutical Inc. vs Xencor, Inc.
R&D Insights: How Rhythm Pharmaceuticals, Inc. and Xencor, Inc. Allocate Funds
Comparing Innovation Spending: Vericel Corporation and Xencor, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Soleno Therapeutics, Inc. and Xencor, Inc.
R&D Spending Showdown: Evotec SE vs Xencor, Inc.